BMJ 2000;320:705-708 ( 11 March )

Education and debate

Joint British recommendations on prevention of coronary heart disease in clinical practice: summary

British Cardiac Society,  British Hyperlipidaemia Association,  British Hypertension Society,  British Diabetic Association. 

Correspondence to: British Cardiac Society, London W1P 5AH David Wood chairman, working party d.wood@ic.ac.uk

The first 150 words of the full text of this article appear below.

	Patients with CHD or other major atherosclerotic disease

For all patients with coronary heart disease (angina, myocardial infarction) or other major atherosclerotic disease, every effort should be made to achieve the lifestyle, risk factor, and therapeutic targets given in the table. The care of coronary patients should embrace all aspects of cardiac prevention and rehabilitation.

Table Removed (Available Only in the Full Text)

Table Removed (Available Only in the Full Text)

	Using the coronary risk prediction chart for primary prevention

These charts are for estimating the risk of coronary heart disease (non-fatal myocardial infarction and death from coronary heart disease) for individuals who have not developed symptoms of coronary heart disease or other major atherosclerotic disease. These charts are not appropriate for patients who have existing disease which already puts them at high risk. Such diseases are:

• Coronary heart disease or other major atherosclerotic disease
• Familial hypercholesterolaemia or other inherited dyslipidaemia
• Established hypertension (systolic BP >160 mm Hg or diastolic >100 mm Hg) or associated target organ damage
• Diabetes mellitus with associated target organ damage
• Renal dysfunction.

Drug treatment is required for all . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Don’t stop taking aspirin

Peter Elwood
BMJ 2008 337: a2581. [Extract] [Full Text]

Aspirin for everyone older than 50?: FOR

Peter Elwood, Gareth Morgan, Ginevra Brown, and Janet Pickering
BMJ 2005 330: 1440-1441. [Extract] [Full Text] [PDF]

Guidelines on preventing cardiovascular disease in clinical practice

Rodney Jackson
BMJ 2000 320: 659-661. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Cleanthis, M, Flather, M. (2009). The dangers of stopping clopidogrel perioperatively: a cardiologist's perspective. Clin Risk 15: 106-108 [Full text]  
• Clarke, M.G., Kennedy, K.P., MacDonagh, R.P. (2009). Development of a Clinical Prediction Model to Calculate Patient Life Expectancy: The Measure of Actuarial Life Expectancy (MALE). Med Decis Making 29: 239-246 [Abstract]  
• Elwood, P. (2008). Don't stop taking aspirin. BMJ 337: a2581-a2581 [Full text]  
• Bulugahapitiya, U, Siyambalapitiya, S, Sithole, J, Fernando, D J, Idris, I (2008). Age threshold for vascular prophylaxis by aspirin in patients without diabetes. Heart 94: 1429-1432 [Abstract] [Full text]  
• Elwood, P., Morgan, G. (2008). Aspirin for all over 50 revisited. Heart 94: 1364-1365 [Full text]  
• Rossi, R., Nuzzo, A., Origliani, G., Modena, M. G. (2008). Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.. J Am Coll Cardiol 51: 997-1002 [Abstract] [Full text]  
• Cubbon, R. M., Wheatcroft, S. B., Grant, P. J., Gale, C. P., Barth, J. H., Sapsford, R. J., Ajjan, R., Kearney, M. T., Hall, A. S., on behalf of the EMMACE (Evaluation of Methods and, (2007). Temporal trends in mortality of patients with diabetes mellitus suffering acute myocardial infarction: a comparison of over 3000 patients between 1995 and 2003. Eur Heart J 28: 540-545 [Abstract] [Full text]  
• Hammerman-Rozenberg, R., Jacobs, J. M., Azoulay, D., Stessman, J. (2006). Aspirin prophylaxis and the prevalence of anaemia. Age Ageing 35: 514-517 [Abstract] [Full text]  
• Mcelduff, P, Jaefarnezhad, M, Durrington, P N (2006). American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively. Heart 92: 1213-1218 [Abstract] [Full text]  
• Bugiardini, R., Manfrini, O., De Ferrari, G. M. (2006). Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography.. Arch Intern Med 166: 1391-1395 [Abstract] [Full text]  
• Mishra, G., Kok, H., Ecob, R., Cooper, R., Hardy, R., Kuh, D. (2006). Cessation of Hormone Replacement Therapy After Reports of Adverse Findings From Randomized Controlled Trials: Evidence From a British Birth Cohort. AJPH 96: 1219-1225 [Abstract] [Full text]  
• Prepared by: British Cardiac Society, British Hype, (2005). JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91: v1-v52 [Full text]  
• Hall, F. C., Dalbeth, N. (2005). Disease modification and cardiovascular risk reduction: two sides of the same coin?. Rheumatology (Oxford) 44: 1473-1482 [Abstract] [Full text]  
• Holman, R. R., Coleman, R. L., Shine, B. S.F., Stevens, R. J. (2005). Non-HDL Cholesterol Is Less Informative Than the Total-to-HDL Cholesterol Ratio in Predicting Cardiovascular Risk in Type 2 Diabetes. Diabetes Care 28: 1796-1797 [Full text]  
• Elwood, P., Morgan, G., Brown, G., Pickering, J. (2005). Aspirin for everyone older than 50?: FOR. BMJ 330: 1440-1441 [Full text]  
• Whiteman, D. C., Green, A. C. (2005). A Risk Prediction Tool for Melanoma?. Cancer Epidemiol. Biomarkers Prev. 14: 761-763 [Full text]  
• Rodriguez-Manas, L., Castro, M., Manzarbeitia, J. (2005). Review: Cardiovascular risk and diabetes in old people. British Journal of Diabetes & Vascular Disease 5: 7-11 [Abstract]  
• Kitas, G. D., Erb, N. (2004). Reply. Rheumatology (Oxford) 43: 114-114 [Full text]  
• Naghavi, M., Libby, P., Falk, E., Casscells, S. W., Litovsky, S., Rumberger, J., Badimon, J. J., Stefanadis, C., Moreno, P., Pasterkamp, G., Fayad, Z., Stone, P. H., Waxman, S., Raggi, P., Madjid, M., Zarrabi, A., Burke, A., Yuan, C., Fitzgerald, P. J., Siscovick, D. S., de Korte, C. L., Aikawa, M., Airaksinen, K. E. J., Assmann, G., Becker, C. R., Chesebro, J. H., Farb, A., Galis, Z. S., Jackson, C., Jang, I.-K., Koenig, W., Lodder, R. A., March, K., Demirovic, J., Navab, M., Priori, S. G., Rekhter, M. D., Bahr, R., Grundy, S. M., Mehran, R., Colombo, A., Boerwinkle, E., Ballantyne, C., Insull, W. Jr, Schwartz, R. S., Vogel, R., Serruys, P. W., Hansson, G. K., Faxon, D. P., Kaul, S., Drexler, H., Greenland, P., Muller, J. E., Virmani, R., Ridker, P. M, Zipes, D. P., Shah, P. K., Willerson, J. T. (2003). From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II. Circulation 108: 1772-1778 [Abstract] [Full text]  
• Oakeshott, P., Kerry, S., Austin, A., Cappuccio, F. (2003). Is there a role for nurse-led blood pressure management in primary care?. Fam Pract 20: 469-473 [Abstract] [Full text]  
• Kitas, G. D., Erb, N. (2003). Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 42: 607-613 [Full text]  
• Belch, J. J. F., Topol, E. J., Agnelli, G., Bertrand, M., Califf, R. M., Clement, D. L., Creager, M. A., Easton, J. D., Gavin, J. R. III, Greenland, P., Hankey, G., Hanrath, P., Hirsch, A. T., Meyer, J., Smith, S. C., Sullivan, F., Weber, M. A. (2003). Critical Issues in Peripheral Arterial Disease Detection and Management: A Call to Action. Arch Intern Med 163: 884-892 [Full text]  
• Hippisley-Cox, J., Cater, R., Pringle, M., Coupland, C. (2003). Cross sectional survey of effectiveness of lipid lowering drugs in reducing serum cholesterol concentration in patients in 17 general practices. BMJ 326: 689-689 [Abstract] [Full text]  
• Feher, M. D, Langley-Hawthorne, C. E, Byrne, C. D (2003). Cost-outcome benefits of fibrate therapy in type 2 diabetes. British Journal of Diabetes & Vascular Disease 3: 124-130 [Abstract]  
• Williams, I. L, Vazir, A., Zaman, A. G (2003). Review: The management of stable angina in diabetes. British Journal of Diabetes & Vascular Disease 3: 18-25 [Abstract]  
• Wood, D A (2002). Preventing clinical heart failure: the rationale and scientific evidence. Heart 88: ii15-22 [Full text]  
• Marteau, T. M, Kinmonth, A. L. (2002). Screening for cardiovascular risk: public health imperative or matter for individual informed choice?. BMJ 325: 78-80 [Full text]  
• Kothari, V., Stevens, R. J., Adler, A. I., Stratton, I. M., Manley, S. E., Neil, H. A., Holman, R. R. (2002). UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine. Stroke 33: 1776-1781 [Abstract] [Full text]  
• Rabindranath, K S, Anderson, N R, Gama, R, Holland, M R (2002). Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation. Postgrad. Med. J. 78: 269-272 [Abstract] [Full text]  
• Devonald, M. A J, Karet, F. E (2002). Targeting the renin-angiotensin system in patients with renal disease. JRSM 95: 391-397 [Full text]  
• Higgins, M (2001). Patients, families and populations at high risk for coronary heart disease. Eur Heart J 22: 1682-1690  
• Baessler, A, Hengstenberg, C, Holmer, S, Fischer, M, Mayer, B, Hubauer, U, Klein, G, Riegger, G, Schunkert, H (2001). Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile. A case-control study in pairs of siblings with myocardial infarction. Eur Heart J 22: 1111-1118 [Abstract]  
• Foggensteiner, L., Mulroy, S., Firth, J. (2001). Management of diabetic nephropathy. JRSM 94: 210-217 [Full text]  
• DURRINGTON, P N, PRAIS, H (2001). Methods for the prediction of coronary heart disease risk. Heart 85: 489-490 [Full text]  
• Jones, A F, Walker, J, Jewkes, C, Game, F L, Bartlett, W A, Marshall, T, Bayly, G R (2001). Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart 85: 37-43 [Abstract] [Full text]  
• Jackson, R. (2000). Guidelines on preventing cardiovascular disease in clinical practice. BMJ 320: 659-661 [Full text]  

Rapid Responses:

Read all Rapid Responses

Unmet Need in Secondary Prevention

Des Spence
bmj.com, 19 Apr 2000 [Full text]

Online poll

Find out more here>> and here>>